TY - JOUR
T1 - Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols
AU - Innocenti, Alessio
AU - Hilvo, Mika
AU - Scozzafava, Andrea
AU - Parkkila, Seppo
AU - Supuran, Claudiu T.
PY - 2008
Y1 - 2008
N2 - Inhibition of the newest isoform of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1), CA XV, with a series of phenols was investigated. Murine CA XV showed an inhibition profile by phenols distinct of those of the cytosolic human isoforms CA I and II. Phenol and some of its 2-, 3-, and 4-substituted derivatives incorporating hydroxy, fluoro, carboxy, and acetamido moieties were effective CA XV inhibitors, with inhibition constants in the range of 7.20–11.30 μM, whereas compounds incorporating 4-amino-, 4-cyano, or 3-hydroxy groups were less effective (KIs of 335–434 μM). The best phenol inhibitor was clioquinol (KI of 2.33 μM). Phenols show a different inhibition mechanism as compared to sulfonamides and their isosteres, and may lead to the design of compounds with selectivity for inhibiting different CA isozymes with medicinal chemistry applications.
AB - Inhibition of the newest isoform of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1), CA XV, with a series of phenols was investigated. Murine CA XV showed an inhibition profile by phenols distinct of those of the cytosolic human isoforms CA I and II. Phenol and some of its 2-, 3-, and 4-substituted derivatives incorporating hydroxy, fluoro, carboxy, and acetamido moieties were effective CA XV inhibitors, with inhibition constants in the range of 7.20–11.30 μM, whereas compounds incorporating 4-amino-, 4-cyano, or 3-hydroxy groups were less effective (KIs of 335–434 μM). The best phenol inhibitor was clioquinol (KI of 2.33 μM). Phenols show a different inhibition mechanism as compared to sulfonamides and their isosteres, and may lead to the design of compounds with selectivity for inhibiting different CA isozymes with medicinal chemistry applications.
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-44849119872&partnerID=MN8TOARS
U2 - 10.1016/j.bmcl.2008.04.077
DO - 10.1016/j.bmcl.2008.04.077
M3 - Article
SN - 0960-894X
VL - 18
SP - 3593
EP - 3596
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 12
ER -